Results 231 to 240 of about 219,205 (349)

Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide. [PDF]

Diagnostics (Basel)
Sali S, Ulaş A, Oyucu Orhan S, Topçu S, Koçar M, Sali M, Ocak B, Deligönül A, Evrensel T, Çubukçu E.   +9 more
europepmc   +1 more source

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

The Lancet Oncology, 2018
Benjamin A. Teply, Hao Wang, Brandon S. Luber, R. Sullivan, Irina Rifkind, Ashley Bruns, A. Spitz, Morgan Decarli, Victoria Sinibaldi, Caroline F. Pratz, Changxue Lu, J. Silberstein, Jun Luo, M. Schweizer, C. Drake, M. Carducci, C. Paller, E. Antonarakis, M. Eisenberger, S. Denmeade   +19 more
semanticscholar   +1 more source

Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial

Veterinary Dermatology, EarlyView.
ABSTRACT Background Targeted antimicrobial therapy for canine otitis externa (OE) represents an opportunity for antimicrobial stewardship. Fosmidomycin selectively inhibits the non‐mevalonate pathway for isoprenoid biosynthesis utilised by canine‐adapted, and not human‐adapted, staphylococci.
Lindsey E. Citron, Darko Stefanovski, Youwen You, Rachel Proctor, Donna Watson, Julie Randall, Christine L. Cain   +6 more
wiley   +1 more source

Drastic Response to Olaparib in a Patient With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA2 Alterations and Near-Threshold Tumor Mutational Burden. [PDF]

IJU Case Rep
Yokota K, Kosaka T, Daimon T, Fujiwara S, Nakamura K, Nishihara H, Oya M.   +6 more
europepmc   +1 more source

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Cancer Research, 2008
R. Montgomery, E. Mostaghel, R. Vessella, D. Hess, T. Kalhorn, C. Higano, L. True, P. Nelson   +7 more
semanticscholar   +1 more source

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study

Veterinary Dermatology, EarlyView.
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda   +3 more
wiley   +1 more source

RETRACTED: Lee et al. Machine-Learning-Based Survival Prediction in Castration-Resistant Prostate Cancer: A Multi-Model Analysis Using a Comprehensive Clinical Dataset. <i>J. Pers. Med.</i> 2025, <i>15</i>, 432. [PDF]

J Pers Med
Lee JH, Jeong J, Ahn YJ, Lee KS, Lee JS, Lee SH, Ham WS, Chung BH, Koo KC.   +8 more
europepmc   +1 more source

Epidemiology of Canine Cutaneous Histiocytoma: Insights From Age and Topographic Clustering

Veterinary Dermatology, EarlyView.
Background: Canine cutaneous histiocytoma (CCH) is a benign Langerhans‐cell tumour that often regresses spontaneously via inflammation. Objectives: To estimate incidence and characterise age and breed–anatomical‐site patterns using two complementary clustering analyses.
C. De Moura, K. Pinello, J. Catarino, J. Niza‐Ribeiro, J. Santos, P. Faísca   +5 more
wiley   +1 more source

Distinct Effects of GnRH Immunocastration Versus Surgical Castration on Gut Microbiota. [PDF]

Animals (Basel)
Kong F, Yang R, Zhou X, Shen Y, Wei W, Zeng X, Du X, Han X.   +7 more
europepmc   +1 more source

Emerging Variants of Castration-Resistant Prostate Cancer

Current Oncology Reports, 2017
P. Vlachostergios, L. Puca, H. Beltran
semanticscholar   +1 more source